Market Value31,543,715
Total Holdings22
File Date2023-05-03
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RARE / Ultragenyx Pharmaceutical Inc.
HTHT / H World Group Limited - Depositary Receipt (Common Stock)
EWZ / iShares, Inc. - iShares MSCI Brazil ETF
AEM / Agnico Eagle Mines Limited
PNT / POINT Biopharma Global Inc.
OXY / Occidental Petroleum Corporation Call
DTIL / Precision BioSciences, Inc.
/ VENTYX BIOSCIENCES INC
FTCH / Farfetch Limited
AMLX / Amylyx Pharmaceuticals, Inc.
CINC / CinCor Pharma Inc
GBIO / Generation Bio Co.
/ Allbirds Inc
US629377CG50 / Nrg Energy Inc Bond
EQT / EQT Corporation
VKTX / Viking Therapeutics, Inc.
SGEN / Seagen Inc
/ HashiCorp Inc
SWN / Southwestern Energy Company
BABA / Alibaba Group Holding Limited - Depositary Receipt (Common Stock)
LRMR / Larimar Therapeutics, Inc.
MSOS / AdvisorShares Trust - AdvisorShares Pure US Cannabis ETF
CCJ / Cameco Corporation
AVTE / Aerovate Therapeutics, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
CBAY / CymaBay Therapeutics, Inc.
TECK / Teck Resources Limited
MGTA / Magenta Therapeutics Inc
GOLD / Gold.com, Inc.
ATVI / Activision Blizzard Inc
MRTX / Mirati Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
MLTX / MoonLake Immunotherapeutics
TVTX / Travere Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
CRC / California Resources Corporation
BILL / BILL Holdings, Inc.
CVE / Cenovus Energy Inc.
RRC / Range Resources Corporation
KALV / KalVista Pharmaceuticals, Inc.
NTCO / Natura &Co Holding S.A. - Depositary Receipt (Common Stock)
SE / Sea Limited - Depositary Receipt (Common Stock)
SRPT / Sarepta Therapeutics, Inc.
HRTX / Heron Therapeutics, Inc.
CHK / Chesapeake Energy Corporation
ATVI / Activision Blizzard Inc Put
XENE / Xenon Pharmaceuticals Inc.
KRE / SPDR Series Trust - State Street SPDR S&P Regional Banking ETF
ACRS / Aclaris Therapeutics, Inc.
OPTN / OptiNose, Inc.
ALBO / Albireo Pharma Inc
RDNT / RadNet, Inc.
ICPT / Intercept Pharmaceuticals Inc
LLY / Eli Lilly and Company
BRY / Berry Corporation
RAPT / RAPT Therapeutics, Inc.
PLRX / Pliant Therapeutics, Inc.
NE / Noble Corporation plc
ISEE / IVERIC bio Inc
PCVX / Vaxcyte, Inc.
SU / Suncor Energy Inc.
PAAS / Pan American Silver Corp.
UBER / Uber Technologies, Inc.
PTCT / PTC Therapeutics, Inc.
OXY / Occidental Petroleum Corporation
OXY.WS / Occidental Petroleum Corporation - Equity Warrant